Update
How we track regulatory status, and why every line has a date
Every compound page carries a regulatory line with the date we last checked it. Here is what that date means and what it does not.
Almost every compound described on this site sits somewhere awkward: not approved for human use, widely sold anyway, and subject to a regulatory position that moves. Sites in this category typically state a status once and leave it, which means a reader has no way to tell whether what they are reading was true last week or in 2021.
So every regulatory line on Bioalmanac carries the date we last checked it, shown on the page rather than buried in metadata. A line dated three months ago is more useful than an undated one that looks current, because you can weigh it.
What the date means is narrow and worth stating precisely. It means a person looked at the relevant regulator's published position on that date and confirmed the sentence still described it. It does not mean the compound was reviewed, that anything was tested, or that a clinician signed off on the rest of the page. The separate review banner is what covers that.
When a status changes, we will post here as well as updating the profile, so the change itself is a citable page rather than a silent edit. The homepage shows the oldest review date across every compound, which means it is visible when we start falling behind.
This page is educational. It describes what published research reports, not what you should do. Peptides discussed here are largely not approved for human use, and nothing on Bioalmanac is medical advice.